Astellas Pharma, Inc.

Japan

  • 1m
  • 3m
  • 6m
  • 1y
  • 2y
  • 5y
May 26, 2017
Prev close: 1,409.5
May 26, 2017
Market cap:
Market cap(USD):
3,035.81B
27,363.23M
Shares: 2,153.82M

Currency in JPY

Company profile

Market(Ticker): TKS(4503)
Sector:
Industry:
Health Technology
Pharmaceuticals: Other
Full time employees: --

Business summary

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

In the news

Financial highlights

Mar 2017

  • Local currency
  • US Dollar
Revenue 1,311.66B
Gross profit 955,325M
Operating income 276,520M
Income before tax 283,633M
Net income 218,701M
EBITDA 340,311M
Diluted EPS 103.55
Dividends per share 34
Total assets 1,820.90B
Total liabilities 548,651M
Total equity 1,271.81B
Operating cash flow 237,230M

Currency in JPY

Revenue 12,112.80M
Gross profit 8,822.11M
Operating income 2,553.57M
Income before tax 2,619.25M
Net income 2,019.63M
EBITDA 3,142.66M
Diluted EPS 0.95
Dividends per share 0.31
Total assets 16,341.20M
Total liabilities 4,923.72M
Total equity 11,413.53M
Operating cash flow 2,190.74M

Currency in USD

Valuation measures

Mar 2017

PER 14.13
ROA 12.08%
ROE 17.28%
Operating margin 21.08%
Profit margin 16.67%

Key executive

  • President, CEO & Representative Director: Yoshihiko Hatanaka
  • Chief Financial Officer: Yasumasa Masuda
  • Senior Executive Officer & President-Technology: Mitsunori Matsuda
  • Representative Director & Executive Vice President: Yoshiro Miyokawa
  • Executive Vice President & General Counsel: Linda Friedman

Share holders

  • Asset Management One Co., Ltd.(5.1%)
  • Astellas Pharma, Inc.(4.0%)
  • Nomura Asset Management Co., Ltd.(3.6%)
  • BlackRock Fund Advisors(3.4%)
  • Nippon Life Insurance Co.(2.9%)
  • The Vanguard Group, Inc.(2.0%)
  • BlackRock Japan Co., Ltd.(2.0%)
  • Fidelity Management & Research Co.(1.8%)
  • Nikko Asset Management Co., Ltd.(1.7%)
  • Daiwa Asset Management Co. Ltd.(1.7%)

Address

  • Website: http://www.astellas.com
  • Address: 2-5-1 Nihonbashi-Honcho, Chuo-Ku, Tokyo, 103-8411, Japan
  • Phone: +81.3.3244.3000

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.